Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- 17 November 2011
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 365 (20), 1886-1895
- https://doi.org/10.1056/nejmoa1014460
Abstract
Maintenance therapy, often with azathioprine or mycophenolate mofetil, is required to consolidate remission and prevent relapse after the initial control of lupus nephritis.Keywords
This publication has 21 references indexed in Scilit:
- Updates on the Treatment of Lupus NephritisJournal of the American Society of Nephrology, 2010
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialAnnals Of The Rheumatic Diseases, 2010
- Mycophenolate Mofetil versus Azathioprine in the Maintenance Therapy of Lupus NephritisRenal Failure, 2008
- Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus NephritisThe New England Journal of Medicine, 2005
- Lupus Nephritis: Induction TherapyLupus, 2005
- Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trialsAmerican Journal of Kidney Diseases, 2004
- Changes in the Incidence of End-stage Renal Disease Due to Lupus Nephritis, 1982-1995Archives of Internal Medicine, 2000
- Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus NephritisThe New England Journal of Medicine, 2000
- Flares in lupus nephritis: incidence, impact on renal survival and management.Lupus, 1998
- Systemic Lupus ErythematosusThe New England Journal of Medicine, 1994